Concepedia

Dacomitinib (PF-00299804), An Irreversible Pan-Her Tyrosine Kinase Inhibitor (TKI), For First-Line Treatment of EGFR-Mutant or Her2-Mutant or -Amplified Lung Cancers

Mark G. Kris, Zelanna Goldberg, Pasi A. Jänne, D. Kim, Renato Martins, Tony Mok, Joseph O’Connell, Sai‐Hong Ignatius Ou, Ian W. Taylor, H. Zhang

Annals of Oncology · 2012 · 22 citations · 0 references

DOIFull text

Open access

Concepts